NovoCure (NVCR) News Today $12.33 +0.31 (+2.58%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$12.32 -0.01 (-0.04%) As of 08/29/2025 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NVCR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period NovoCure (NASDAQ:NVCR) Shares Down 5.3% - Here's What HappenedAugust 27, 2025 | marketbeat.comImmunityBio rises on data for NK cell therapy, device combo for glioblastomaAugust 26, 2025 | msn.comNovocure announces coverage for Tumor Treating Fields therapy in SpainAugust 25, 2025 | msn.comNovoCure Limited $NVCR Shares Purchased by Algert Global LLCAugust 24, 2025 | marketbeat.com693,768 Shares in NovoCure Limited $NVCR Bought by Nuveen LLCAugust 24, 2025 | marketbeat.comVanguard Group Inc. Cuts Stake in NovoCure Limited $NVCRAugust 22, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Receives $28.79 Average PT from AnalystsAugust 21, 2025 | americanbankingnews.comNovocure submits Tumor Treating Fields therapy premarket approval applicationAugust 20, 2025 | msn.comNovocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic CancerAugust 20, 2025 | finance.yahoo.comNovoCure Limited (NASDAQ:NVCR) Receives Average Rating of "Moderate Buy" from BrokeragesAugust 19, 2025 | marketbeat.comLeerink Partners Reiterates a Buy Rating on NovoCure Limited (NVCR)August 13, 2025 | msn.comConnor Clark & Lunn Investment Management Ltd. Increases Stake in NovoCure Limited (NASDAQ:NVCR)August 13, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Hits New 1-Year Low - Here's WhyAugust 12, 2025 | marketbeat.comFederated Hermes Inc. Sells 687,912 Shares of NovoCure Limited (NASDAQ:NVCR)August 5, 2025 | marketbeat.comTD Asset Management Inc Sells 204,942 Shares of NovoCure Limited (NASDAQ:NVCR)August 5, 2025 | marketbeat.comGSA Capital Partners LLP Makes New Investment in NovoCure Limited (NASDAQ:NVCR)August 2, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Trading 9.3% Higher on Insider Buying ActivityAugust 1, 2025 | marketbeat.comNovoCure: Cash Burn, A Costly Launch, And A Maturing Business Signal More Pain AheadAugust 1, 2025 | seekingalpha.comInsider Buying: NovoCure Limited (NASDAQ:NVCR) CFO Purchases 20,000 Shares of StockJuly 31, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Hits New 52-Week Low - Time to Sell?July 31, 2025 | marketbeat.comChristoph Brackmann Buys 20,000 Shares of NovoCure Limited (NASDAQ:NVCR) StockJuly 31, 2025 | insidertrades.comNovoCure's Wearable Oncology Edge And Compelling ValuationJuly 30, 2025 | seekingalpha.comNovoCure Limited (NASDAQ:NVCR) Q2 2025 Earnings Call TranscriptJuly 29, 2025 | msn.comBaillie Gifford & Co. Sells 24,330 Shares of NovoCure Limited (NASDAQ:NVCR)July 27, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Trading Down 5.6% - Should You Sell?July 26, 2025 | marketbeat.comWells Fargo & Company Reaffirms Equal Weight Rating for NovoCure (NASDAQ:NVCR)July 26, 2025 | marketbeat.comWells Fargo Downgrades NovoCure (NVCR)July 26, 2025 | msn.comNovoCure Q2 Revenue Jumps 6 PercentJuly 25, 2025 | theglobeandmail.comNovoCure Limited (NVCR) Q2 2025 Earnings Call TranscriptJuly 25, 2025 | seekingalpha.comNovoCure Limited 2025 Q2 - Results - Earnings Call PresentationJuly 25, 2025 | seekingalpha.comNovoCure (NASDAQ:NVCR) Sets New 52-Week Low - Here's WhyJuly 25, 2025 | marketbeat.comNovocure: Steady Ahead of Key MilestonesJuly 24, 2025 | msn.comNovocure Reports Second Quarter 2025 Financial ResultsJuly 24, 2025 | businesswire.com32,179 Shares in NovoCure Limited (NASDAQ:NVCR) Purchased by Jennison Associates LLCJuly 23, 2025 | marketbeat.comHussman Strategic Advisors Inc. Purchases New Stake in NovoCure Limited (NASDAQ:NVCR)July 18, 2025 | marketbeat.comEdgestream Partners L.P. Makes New Investment in NovoCure Limited (NASDAQ:NVCR)July 17, 2025 | marketbeat.comNovoCure (NVCR) Projected to Post Earnings on ThursdayJuly 17, 2025 | marketbeat.comLadenburg Thalmann Initiates Coverage of NovoCure (NVCR) with Buy RecommendationJuly 9, 2025 | msn.comNovoCure (NASDAQ:NVCR) Coverage Initiated at LADENBURG THALM/SH SHJuly 8, 2025 | marketbeat.comSummit Trail Advisors LLC Acquires 40,570 Shares of NovoCure Limited (NASDAQ:NVCR)July 2, 2025 | marketbeat.comStrong week for NovoCure (NASDAQ:NVCR) shareholders doesn't alleviate pain of three-year lossJune 30, 2025 | finance.yahoo.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Taylor Frigon Capital Management LLCJune 30, 2025 | marketbeat.comNovocure to Report Second Quarter 2025 Financial ResultsJune 30, 2025 | businesswire.comNovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of "Moderate Buy" by AnalystsJune 29, 2025 | marketbeat.comDemystifying NovoCure: Insights From 4 Analyst ReviewsJune 27, 2025 | benzinga.comNovoCure's (NVCR) "Overweight" Rating Reiterated at Piper SandlerJune 27, 2025 | marketbeat.comSG Americas Securities LLC Invests $527,000 in NovoCure Limited (NASDAQ:NVCR)June 23, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Shares Down 3.4% - What's Next?June 18, 2025 | marketbeat.comGAMMA Investing LLC Purchases 47,152 Shares of NovoCure Limited (NASDAQ:NVCR)June 17, 2025 | marketbeat.comSimon Quick Advisors LLC Takes Position in NovoCure Limited (NASDAQ:NVCR)June 16, 2025 | marketbeat.com Get NovoCure News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NVCR Media Mentions By Week NVCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVCR News Sentiment▼0.841.09▲Average Medical News Sentiment NVCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVCR Articles This Week▼55▲NVCR Articles Average Week Get the Latest News and Ratings for NVCR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for NovoCure and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies iRhythm Technologies News Glaukos News Bausch + Lomb News TransMedics Group News Soleno Therapeutics News Envista News LivaNova News Inspire Medical Systems News Warby Parker News Liquidia Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVCR) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NovoCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
